Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.

Larrat S, Kulkarni O, Claude JB, Beugnot R, Blum MG, Fusillier K, Lupo J, Tremeaux P, Plages A, Marlu A, Duborjal H, Signori-Schmuck A, Francois O, Zarski JP, Morand P, Leroy V.

J Clin Microbiol. 2015 Feb;53(2):389-97. doi: 10.1128/JCM.02547-14. Epub 2014 Nov 19.

2.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.

Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study..

Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16.

PMID:
24102852
3.

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.

Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E; ANRS HCEP 23 Fibrostar Group..

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):467-72. doi: 10.1016/j.clinre.2013.07.003. Epub 2013 Aug 8.

PMID:
23932706
4.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR..

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
5.

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).

Couzigou P, Pérusat S, Bourlière M, Trimoulet P, Poynard T, Leroy V, Marcellin P, Foucher J, Bronowicki JP, Chêne G; ANRS HC16 GAMMATRI Trial Group..

J Gastroenterol Hepatol. 2013 Feb;28(2):329-34. doi: 10.1111/jgh.12060.

PMID:
23190183
6.

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group..

Clin Chim Acta. 2013 Jan 16;415:63-8. doi: 10.1016/j.cca.2012.09.020. Epub 2012 Sep 27.

PMID:
23022619
7.

Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, Calès P; Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies..

Hepatology. 2013 Mar;57(3):1182-91. doi: 10.1002/hep.25993. Epub 2013 Feb 4.

PMID:
22899556
8.

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.

Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP; ANRS HC EP 23 Fibrostar Study Group..

Clin Chem Lab Med. 2012 Jan 13;50(4):693-9. doi: 10.1515/cclm-2011-0858.

PMID:
22505560
9.

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies..

Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654.

PMID:
21898504
10.

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).

Halfon P, Pérusat S, Bourlière M, Bronowicki JP, Trimoulet P, Benhamou Y, Leroy V, Marcellin P, Foucher J, Penaranda G, Chêne G, Couzigou P; ANRS HC16 GAMMATRI Study Group..

J Med Virol. 2010 Dec;82(12):2027-31. doi: 10.1002/jmv.21909.

PMID:
20981789
11.

Optimization and robustness of blood tests for liver fibrosis and cirrhosis.

Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC; multicentric groups (SNIFF 14 & 17, ANRS HC EP 23 Fibrostar)..

Clin Biochem. 2010 Nov;43(16-17):1315-22. doi: 10.1016/j.clinbiochem.2010.08.010. Epub 2010 Aug 14.

PMID:
20713037
12.

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.

Levast M, Larrat S, Thelu MA, Nicod S, Plages A, Cheveau A, Zarski JP, Seigneurin JM, Morand P, Leroy V.

J Med Virol. 2010 May;82(5):747-54. doi: 10.1002/jmv.21695.

PMID:
20336715
13.

Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort.

Guéchot J, Lasnier E, Sturm N, Paris A, Zarski JP; ANRS HC EP 23 Fibrostar study group..

Clin Chim Acta. 2010 Jan;411(1-2):86-91. doi: 10.1016/j.cca.2009.10.011. Epub 2009 Oct 19.

PMID:
19850017
14.

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial.

Sturm N, Bronowicki JP, Maynard-Muet M, Tran A, Heluwaert F, Plages A, Zarski JP.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):984-6. doi: 10.1016/j.gcb.2009.05.010. Epub 2009 Jul 30. No abstract available.

15.

Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure.

Zoulim F, Parvaz P, Marcellin P, Zarski JP, Beaugrand M, Benhamou Y, Bailly F, Maynard M, Trepo C, Trylesinski A, Monchecourt F; VIRESPA study group..

Liver Int. 2009 Mar;29(3):420-6. doi: 10.1111/j.1478-3231.2008.01867.x. Epub 2008 Sep 15.

PMID:
18795900
16.

Ribavirin quantification in combination treatment of chronic hepatitis C.

Larrat S, Stanke-Labesque F, Plages A, Zarski JP, Bessard G, Souvignet C.

Antimicrob Agents Chemother. 2003 Jan;47(1):124-9.

17.

Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial.

Zarski JP, Barange K, Souvignet C, Bertini M, Marcellin P, Tran A, Deugnier Y, Couzigou P, Plages A, Ambroise-Thomas P.

J Hepatol. 2001 Mar;34(3):486-8. No abstract available.

PMID:
11322216

Supplemental Content

Loading ...
Support Center